British–Swedish multinational pharmaceutical firm AstraZeneca ha...
QIAGEN N.V. has announced the U.S. launch of the new Access Anti-SARS-...
The U.S. Food and Drug Administration (FDA) has issued an emergency us...
American multinational firm Johnson & Johnson has entered into a d...
US based Regeneron Pharmaceuticals, Inc. and Swiss firm Roche have ann...
CARE (Corona Accelerated R&D in Europe) a new consortium supported...
French multinational pharmaceutical firm Sanofi and Principia Bio...
German multinational pharmaceutical and life sciences company Bayer an...
Two Phase 3, randomized, placebo-controlled, double-blind clinical tri...
Recent reports from Russia claim that one of their COVID-19 vaccine ca...
German fim Siemens Healthineers has announced that it has received FDA...
German firm Siemens Healthineers AG and Varian Medical Systems, Inc. i...
Paris based DNA synthesis company DNA Script has announced a $50 milli...
Swiss firm Roche has announced that the phase III COVACTA study of Act...
Piramal Pharma Solutions, a leading contract development and manufactu...
US based Piramal Critical Care (PCC), a business unit of Piramal ...
Swiss firm Novartis has announced a new initiative to help patients in...
Leading global provider of advanced analytics, technology solutions an...
